Related Experiment Video
Updated: Oct 6, 2025

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions
Published on: August 2, 2018
Interaction Among Noncoding RNAs, DNA Damage Reactions, and Genomic Instability in the Hypoxic Tumor: Is it
Suman Kumar Ray1, Sukhes Mukherjee2
1Independent Researcher, India.
Abstract:
Hypoxia is a classical function of the tumor's microenvironment with a substantial effect on the development and therapeutic response of cancer. When put in hypoxic environments, cells undergo several biological reactions, including activation of signaling pathways that control proliferation, angiogenesis, and death. These pathways have been adapted by cancer cells to allow tumors to survive and even develop in hypoxic conditions, and poor prognosis is associated with tumor hypoxia. The most relevant transcriptional regulator in response to hypoxia, Hypoxia-inducible factor-1 alpha (HIF-1α), has been shown to modulate hypoxic gene expression and signaling transduction networks significantly. The significance of non-coding RNAs in hypoxic tumor regions has been revealed in an increasing number of studies over the past few decades. In regulating hypoxic gene expression, these hypoxia-responsive ncRNAs play pivotal roles. Hypoxia, a general characteristic of the tumor's microenvironment, significantly affects the expression of genes and is closely associated with the development of cancer. Indeed, the number of known hypoxia-associated lncRNAs has increased dramatically, demonstrating the growing role of lncRNAs in cascades and responses to hypoxia signaling. Decades of research have helped us create an image of the shift in hypoxic cancer cells' DNA repair capabilities. Emerging evidence suggests that hypoxia can trigger genetic instability in cancer cells because of microenvironmental tumor stress. Researchers have found that critical genes' expression is coordinately repressed by hypoxia within the DNA damage and repair pathways. In this study, we include an update of current knowledge on the presentation, participation, and potential clinical effect of ncRNAs in tumor hypoxia, DNA damage reactions, and genomic instability, with a specific emphasis on their unusual cascade of molecular regulation and malignant progression induced by hypoxia.
Insights
Tumor hypoxia, a hallmark of cancer, drives tumor progression and therapeutic resistance. Hypoxia-responsive non-coding RNAs (ncRNAs) significantly impact gene expression, DNA repair, and genomic instability in cancer cells, influencing outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Tumor hypoxia is a critical factor influencing cancer development, progression, and treatment response.
- Hypoxia activates signaling pathways controlling cell proliferation, angiogenesis, and survival, often exploited by cancer cells.
- Hypoxia-inducible factor-1 alpha (HIF-1α) is a key regulator of gene expression in response to low oxygen environments.
Purpose of the Study:
- To review the role of non-coding RNAs (ncRNAs) in tumor hypoxia.
- To explore the involvement of ncRNAs in DNA damage responses and genomic instability within hypoxic tumors.
- To highlight the clinical implications of ncRNAs in managing hypoxic cancers.
Main Methods:
- Literature review and synthesis of current research on ncRNAs, hypoxia, and cancer.
- Analysis of molecular mechanisms linking hypoxia, ncRNAs, and genomic alterations.
- Discussion of emerging evidence on the clinical relevance of these interactions.
Main Results:
- Hypoxia significantly alters gene expression, with ncRNAs playing crucial regulatory roles.
- Hypoxia-responsive ncRNAs are increasingly recognized for their involvement in cancer progression.
- Evidence suggests hypoxia-induced genetic instability is mediated, in part, by altered DNA repair pathways influenced by ncRNAs.
Conclusions:
- ncRNAs are pivotal in mediating cancer cell adaptation and progression under hypoxic conditions.
- Understanding the interplay between ncRNAs, hypoxia, DNA damage, and genomic instability is crucial for developing novel cancer therapies.
- ncRNAs represent potential therapeutic targets and biomarkers for hypoxic tumors.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Regulation of Angiogenesis and Blood Supply
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Epigenetic Regulation
X-chromosome...
lncRNA - Long Non-coding RNAs

